Popular Articles

Indian Health Service Loses Equipment At Alarming Rate
The Associated Press reports that "the Indian Health Service is continuing to lose equipment at an alarming rate despite efforts to better account for the agency"s property, according to congressional investigators. In a report issued Wednesday, the Government Accountability Office said the government agency lost about 1,400 items worth $3.5 million between October 2007 and January 2009 - including $37,000 in lab equipment at a Navajo health care facility and a $7,300 trailer in Nashville, Tenn. Those losses came after an estimated $15.8 million in equipment was unaccounted for between the 2004 and 2007 budget years. Those losses were reported by the GAO in June 2008, when investigators also charged that the Indian Health Service had falsified documents to cover up some of the missing property."
new payday loan lenders
Programs Bring Innovation To Palliative And End-of-Life Care
Three programs that expand the reach of palliative and end-of-life care will be recognized as the 2009 recipients of the Circle of Life Award®: Celebrating Innovation in End-of-Life Care, along with two others that were awarded citations of honor.
News of the day
Positive, Clinically Significant Phase III Results For Personalized Anti-Cancer Vaccine, BiovaxID®, Presented At ASCO Plenary Session
Biovest International, Inc. (Other OTC: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC: ABPIQ) announced that an eight year pivotal, randomized, multi-center, double-blind, controlled Phase III clinical study has shown that BiovaxID® (personalized therapeutic anti-cancer vaccine) significantly prolonged disease-free survival in follicular non-Hodgkin"s lymphoma. The study, which is being featured at today"s American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session, found that patients who received BiovaxID experienced a median disease-free survival of 44.2 months compared to 30.6 months for those who received a control vaccine - an increase of 47 percent. In the study, with a median follow-up of 4.7 years, patients receiving BiovaxID experienced a 38% lower risk of disease recurrence compared to patients receiving the control vaccine. BiovaxID is the first ever vaccine targeting lymphoma to demonstrate such a disease-free survival benefit.
Mental Health

Alzheimer, Headache & Co.: Detecting Neurological Illnesses Better And Earlier

The rapid development of modern neuroimaging has made a decisive improvement in the diagnosis of neurological illnesses. As Professor Filippi notes: "Neuroimaging makes new diagnostic tools available with the potential to quantify the extent of CNS injury, to define the nature of the different pathological substrates of the various CNS affections and to assess the functional changes following tissue damage with the ability to limit the clinical consequences of injury." The research team of Professor Filippi is presenting a study at the ENS Congress that could contribute to better distinguishing between Alzheimer"s disease and the normal aging processes of the brain. With the help of diffusion tensor magnetic resonance imaging (DT-MRI), researchers examined the white matter changes in healthy persons, in those with Alzheimer"s and in patients with cognitive impairment. Sure enough, differences appear, as the study shows: The major brain fibre bundles show diffusivity alterations which followed the trajectory normal ageing - mild cognitive impairment - Alzheimer"s disease. In another very frequently occurring disease, modern neuroimaging is also delivering important new findings: a separate study being presented at the Milan Congress compared - using functional magnetic resonance imaging (fMRI) - specific neuronal networks between healthy people and those with cluster headache. "The analysis of resting states networks reveals abnormalities of the visual and motor networks in cluster headache patients outside the acute attack," the Milan researches noted in summarizing their results. "These findings suggest a diffuse dysfunction of functional connectivity which extends beyond the antinoceptive system." Another current work of the research team shows the usefulness of modern neuroimaging for the early detection of amyotrophic lateral sclerosis (ALS). ALS is the most common adult-onset motor neuron disease with a dramatic course. The diagnosis of ALS is based on clinical criteria and no diagnostic biomarkers objectively assessing damage to the corticospinal tracts are available, making the early diagnosis especially difficult. That might change. Professor Filippi: "We were able to show with diffusion tensor MRI tractography that - compared with controls - ALS patients with mild disability have a clear damage to the corticospinal tracts." European Neurological Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):